nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP3A4—Fingolimod—multiple sclerosis	0.13	0.206	CbGbCtD
Benzphetamine—CYP2B6—Dexamethasone—multiple sclerosis	0.103	0.163	CbGbCtD
Benzphetamine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0835	0.132	CbGbCtD
Benzphetamine—CYP3A4—Triamcinolone—multiple sclerosis	0.0633	0.1	CbGbCtD
Benzphetamine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0609	0.0967	CbGbCtD
Benzphetamine—CYP3A4—Betamethasone—multiple sclerosis	0.0543	0.0861	CbGbCtD
Benzphetamine—CYP3A4—Prednisolone—multiple sclerosis	0.0536	0.085	CbGbCtD
Benzphetamine—CYP3A4—Prednisone—multiple sclerosis	0.0506	0.0803	CbGbCtD
Benzphetamine—CYP3A4—Dexamethasone—multiple sclerosis	0.0316	0.0501	CbGbCtD
Benzphetamine—SLC6A3—nerve—multiple sclerosis	0.0131	0.0835	CbGeAlD
Benzphetamine—SLC6A2—nerve—multiple sclerosis	0.0106	0.0673	CbGeAlD
Benzphetamine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00961	0.0611	CbGeAlD
Benzphetamine—SLC18A2—brainstem—multiple sclerosis	0.00746	0.0474	CbGeAlD
Benzphetamine—SLC6A3—brainstem—multiple sclerosis	0.00564	0.0358	CbGeAlD
Benzphetamine—POR—medulla oblongata—multiple sclerosis	0.00545	0.0347	CbGeAlD
Benzphetamine—SLC18A2—medulla oblongata—multiple sclerosis	0.0052	0.033	CbGeAlD
Benzphetamine—Cardiomyopathy—Mitoxantrone—multiple sclerosis	0.00505	0.0585	CcSEcCtD
Benzphetamine—POR—midbrain—multiple sclerosis	0.00498	0.0317	CbGeAlD
Benzphetamine—POR—spinal cord—multiple sclerosis	0.00486	0.0309	CbGeAlD
Benzphetamine—SLC18A2—midbrain—multiple sclerosis	0.00475	0.0302	CbGeAlD
Benzphetamine—SLC6A2—brainstem—multiple sclerosis	0.00455	0.0289	CbGeAlD
Benzphetamine—ADRA1A—brainstem—multiple sclerosis	0.00423	0.0269	CbGeAlD
Benzphetamine—SLC18A2—nervous system—multiple sclerosis	0.00391	0.0248	CbGeAlD
Benzphetamine—POR—cerebellum—multiple sclerosis	0.00386	0.0245	CbGeAlD
Benzphetamine—SLC18A2—central nervous system—multiple sclerosis	0.00376	0.0239	CbGeAlD
Benzphetamine—SLC18A2—cerebellum—multiple sclerosis	0.00368	0.0234	CbGeAlD
Benzphetamine—SLC6A3—midbrain—multiple sclerosis	0.00359	0.0228	CbGeAlD
Benzphetamine—SLC6A3—spinal cord—multiple sclerosis	0.00351	0.0223	CbGeAlD
Benzphetamine—SLC6A2—medulla oblongata—multiple sclerosis	0.00317	0.0202	CbGeAlD
Benzphetamine—POR—brain—multiple sclerosis	0.00313	0.0199	CbGeAlD
Benzphetamine—SLC18A2—brain—multiple sclerosis	0.00299	0.019	CbGeAlD
Benzphetamine—SLC6A3—nervous system—multiple sclerosis	0.00295	0.0188	CbGeAlD
Benzphetamine—SLC6A3—central nervous system—multiple sclerosis	0.00284	0.0181	CbGeAlD
Benzphetamine—SLC6A3—cerebellum—multiple sclerosis	0.00278	0.0177	CbGeAlD
Benzphetamine—Palpitations—Fingolimod—multiple sclerosis	0.00268	0.031	CcSEcCtD
Benzphetamine—SLC6A2—nervous system—multiple sclerosis	0.00238	0.0151	CbGeAlD
Benzphetamine—SLC6A2—central nervous system—multiple sclerosis	0.00229	0.0146	CbGeAlD
Benzphetamine—SLC6A3—brain—multiple sclerosis	0.00226	0.0143	CbGeAlD
Benzphetamine—ADRA2A—medulla oblongata—multiple sclerosis	0.00224	0.0142	CbGeAlD
Benzphetamine—ADRA1A—nervous system—multiple sclerosis	0.00222	0.0141	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00213	0.0247	CcSEcCtD
Benzphetamine—ADRA1A—central nervous system—multiple sclerosis	0.00213	0.0136	CbGeAlD
Benzphetamine—ADRA1A—cerebellum—multiple sclerosis	0.00209	0.0132	CbGeAlD
Benzphetamine—ADRA2A—midbrain—multiple sclerosis	0.00205	0.013	CbGeAlD
Benzphetamine—ADRA2A—spinal cord—multiple sclerosis	0.002	0.0127	CbGeAlD
Benzphetamine—SLC6A2—brain—multiple sclerosis	0.00182	0.0116	CbGeAlD
Benzphetamine—CYP2B6—nervous system—multiple sclerosis	0.00176	0.0112	CbGeAlD
Benzphetamine—ADRA1A—brain—multiple sclerosis	0.00169	0.0108	CbGeAlD
Benzphetamine—Diarrhoea—Fingolimod—multiple sclerosis	0.00169	0.0196	CcSEcCtD
Benzphetamine—CYP2B6—central nervous system—multiple sclerosis	0.00169	0.0107	CbGeAlD
Benzphetamine—ADRA2A—nervous system—multiple sclerosis	0.00168	0.0107	CbGeAlD
Benzphetamine—Dizziness—Fingolimod—multiple sclerosis	0.00163	0.019	CcSEcCtD
Benzphetamine—ADRA2A—central nervous system—multiple sclerosis	0.00162	0.0103	CbGeAlD
Benzphetamine—Trimethaphan—BCHE—multiple sclerosis	0.00162	0.481	CrCbGaD
Benzphetamine—ADRA2A—cerebellum—multiple sclerosis	0.00159	0.0101	CbGeAlD
Benzphetamine—Headache—Fingolimod—multiple sclerosis	0.00155	0.018	CcSEcCtD
Benzphetamine—Sweating—Mitoxantrone—multiple sclerosis	0.00138	0.0161	CcSEcCtD
Benzphetamine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.00138	0.016	CcSEcCtD
Benzphetamine—Tachycardia—Cladribine—multiple sclerosis	0.00137	0.0159	CcSEcCtD
Benzphetamine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00135	0.0157	CcSEcCtD
Benzphetamine—CYP2B6—brain—multiple sclerosis	0.00134	0.00853	CbGeAlD
Benzphetamine—Anorexia—Cladribine—multiple sclerosis	0.00134	0.0155	CcSEcCtD
Benzphetamine—CYP3A4—nervous system—multiple sclerosis	0.00133	0.00843	CbGeAlD
Benzphetamine—ADRA2A—brain—multiple sclerosis	0.00129	0.00818	CbGeAlD
Benzphetamine—CYP3A4—central nervous system—multiple sclerosis	0.00128	0.00811	CbGeAlD
Benzphetamine—Insomnia—Cladribine—multiple sclerosis	0.00127	0.0147	CcSEcCtD
Benzphetamine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.00125	0.0145	CcSEcCtD
Benzphetamine—Psychotic disorder—Betamethasone—multiple sclerosis	0.00125	0.0145	CcSEcCtD
Benzphetamine—Decreased appetite—Cladribine—multiple sclerosis	0.00122	0.0141	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00121	0.014	CcSEcCtD
Benzphetamine—Urticaria—Cladribine—multiple sclerosis	0.00111	0.0129	CcSEcCtD
Benzphetamine—Psychotic disorder—Prednisone—multiple sclerosis	0.00109	0.0127	CcSEcCtD
Benzphetamine—Sweating—Methylprednisolone—multiple sclerosis	0.00104	0.0121	CcSEcCtD
Benzphetamine—Hypersensitivity—Cladribine—multiple sclerosis	0.00103	0.012	CcSEcCtD
Benzphetamine—Ethopropazine—BCHE—multiple sclerosis	0.00103	0.306	CrCbGaD
Benzphetamine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000984	0.0114	CcSEcCtD
Benzphetamine—Diarrhoea—Cladribine—multiple sclerosis	0.000959	0.0111	CcSEcCtD
Benzphetamine—Dizziness—Cladribine—multiple sclerosis	0.000927	0.0107	CcSEcCtD
Benzphetamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000899	0.0104	CcSEcCtD
Benzphetamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00089	0.0103	CcSEcCtD
Benzphetamine—Anorexia—Mitoxantrone—multiple sclerosis	0.000878	0.0102	CcSEcCtD
Benzphetamine—Headache—Cladribine—multiple sclerosis	0.000878	0.0102	CcSEcCtD
Benzphetamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000839	0.00973	CcSEcCtD
Benzphetamine—Nausea—Cladribine—multiple sclerosis	0.000832	0.00965	CcSEcCtD
Benzphetamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000811	0.0094	CcSEcCtD
Benzphetamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000801	0.00928	CcSEcCtD
Benzphetamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00078	0.00904	CcSEcCtD
Benzphetamine—Dizziness—Azathioprine—multiple sclerosis	0.000753	0.00874	CcSEcCtD
Benzphetamine—Tachycardia—Prednisolone—multiple sclerosis	0.000738	0.00855	CcSEcCtD
Benzphetamine—Urticaria—Mitoxantrone—multiple sclerosis	0.000732	0.00848	CcSEcCtD
Benzphetamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000731	0.00847	CcSEcCtD
Benzphetamine—Headache—Azathioprine—multiple sclerosis	0.000714	0.00828	CcSEcCtD
Benzphetamine—Sweating—Methotrexate—multiple sclerosis	0.00069	0.008	CcSEcCtD
Benzphetamine—Insomnia—Prednisolone—multiple sclerosis	0.000683	0.00793	CcSEcCtD
Benzphetamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000679	0.00787	CcSEcCtD
Benzphetamine—Tachycardia—Triamcinolone—multiple sclerosis	0.000678	0.00786	CcSEcCtD
Benzphetamine—Nausea—Azathioprine—multiple sclerosis	0.000677	0.00785	CcSEcCtD
Benzphetamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000677	0.00785	CcSEcCtD
Benzphetamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000672	0.00779	CcSEcCtD
Benzphetamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00067	0.00777	CcSEcCtD
Benzphetamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00063	0.00731	CcSEcCtD
Benzphetamine—Insomnia—Triamcinolone—multiple sclerosis	0.000629	0.00729	CcSEcCtD
Benzphetamine—Insomnia—Methylprednisolone—multiple sclerosis	0.000627	0.00727	CcSEcCtD
Benzphetamine—Agitation—Prednisone—multiple sclerosis	0.000618	0.00717	CcSEcCtD
Benzphetamine—Tachycardia—Betamethasone—multiple sclerosis	0.000615	0.00714	CcSEcCtD
Benzphetamine—Tachycardia—Dexamethasone—multiple sclerosis	0.000615	0.00714	CcSEcCtD
Benzphetamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000612	0.00709	CcSEcCtD
Benzphetamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00061	0.00708	CcSEcCtD
Benzphetamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00061	0.00707	CcSEcCtD
Benzphetamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00061	0.00707	CcSEcCtD
Benzphetamine—Anorexia—Betamethasone—multiple sclerosis	0.000601	0.00697	CcSEcCtD
Benzphetamine—Anorexia—Dexamethasone—multiple sclerosis	0.000601	0.00697	CcSEcCtD
Benzphetamine—Urticaria—Prednisolone—multiple sclerosis	0.0006	0.00696	CcSEcCtD
Benzphetamine—Headache—Mitoxantrone—multiple sclerosis	0.000577	0.00669	CcSEcCtD
Benzphetamine—Insomnia—Dexamethasone—multiple sclerosis	0.00057	0.00661	CcSEcCtD
Benzphetamine—Insomnia—Betamethasone—multiple sclerosis	0.00057	0.00661	CcSEcCtD
Benzphetamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000557	0.00646	CcSEcCtD
Benzphetamine—Dyspepsia—Betamethasone—multiple sclerosis	0.000555	0.00644	CcSEcCtD
Benzphetamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000555	0.00644	CcSEcCtD
Benzphetamine—Urticaria—Triamcinolone—multiple sclerosis	0.000552	0.0064	CcSEcCtD
Benzphetamine—Urticaria—Methylprednisolone—multiple sclerosis	0.000551	0.00639	CcSEcCtD
Benzphetamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000548	0.00636	CcSEcCtD
Benzphetamine—Decreased appetite—Betamethasone—multiple sclerosis	0.000548	0.00636	CcSEcCtD
Benzphetamine—Nausea—Mitoxantrone—multiple sclerosis	0.000547	0.00634	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000544	0.00631	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000544	0.00631	CcSEcCtD
Benzphetamine—Tachycardia—Prednisone—multiple sclerosis	0.000536	0.00621	CcSEcCtD
Benzphetamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000531	0.00616	CcSEcCtD
Benzphetamine—Anorexia—Prednisone—multiple sclerosis	0.000523	0.00607	CcSEcCtD
Benzphetamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000512	0.00594	CcSEcCtD
Benzphetamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000511	0.00592	CcSEcCtD
Benzphetamine—Urticaria—Dexamethasone—multiple sclerosis	0.000501	0.00581	CcSEcCtD
Benzphetamine—Urticaria—Betamethasone—multiple sclerosis	0.000501	0.00581	CcSEcCtD
Benzphetamine—Dizziness—Prednisolone—multiple sclerosis	0.0005	0.00579	CcSEcCtD
Benzphetamine—Insomnia—Prednisone—multiple sclerosis	0.000497	0.00576	CcSEcCtD
Benzphetamine—Dyspepsia—Prednisone—multiple sclerosis	0.000483	0.0056	CcSEcCtD
Benzphetamine—Decreased appetite—Prednisone—multiple sclerosis	0.000477	0.00554	CcSEcCtD
Benzphetamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000474	0.0055	CcSEcCtD
Benzphetamine—Headache—Prednisolone—multiple sclerosis	0.000473	0.00549	CcSEcCtD
Benzphetamine—Dizziness—Triamcinolone—multiple sclerosis	0.00046	0.00533	CcSEcCtD
Benzphetamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000459	0.00532	CcSEcCtD
Benzphetamine—Nausea—Prednisolone—multiple sclerosis	0.000449	0.0052	CcSEcCtD
Benzphetamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000444	0.00514	CcSEcCtD
Benzphetamine—Anorexia—Methotrexate—multiple sclerosis	0.000437	0.00507	CcSEcCtD
Benzphetamine—Phenprocoumon—ALB—multiple sclerosis	0.000437	0.13	CrCbGaD
Benzphetamine—Urticaria—Prednisone—multiple sclerosis	0.000436	0.00506	CcSEcCtD
Benzphetamine—Headache—Triamcinolone—multiple sclerosis	0.000435	0.00505	CcSEcCtD
Benzphetamine—Headache—Methylprednisolone—multiple sclerosis	0.000434	0.00504	CcSEcCtD
Benzphetamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000431	0.005	CcSEcCtD
Benzphetamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000431	0.005	CcSEcCtD
Benzphetamine—Dizziness—Dexamethasone—multiple sclerosis	0.000417	0.00483	CcSEcCtD
Benzphetamine—Dizziness—Betamethasone—multiple sclerosis	0.000417	0.00483	CcSEcCtD
Benzphetamine—Insomnia—Methotrexate—multiple sclerosis	0.000415	0.00481	CcSEcCtD
Benzphetamine—Nausea—Triamcinolone—multiple sclerosis	0.000413	0.00479	CcSEcCtD
Benzphetamine—Nausea—Methylprednisolone—multiple sclerosis	0.000412	0.00478	CcSEcCtD
Benzphetamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000405	0.00469	CcSEcCtD
Benzphetamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000404	0.00468	CcSEcCtD
Benzphetamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000399	0.00463	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000396	0.00459	CcSEcCtD
Benzphetamine—Headache—Betamethasone—multiple sclerosis	0.000395	0.00458	CcSEcCtD
Benzphetamine—Headache—Dexamethasone—multiple sclerosis	0.000395	0.00458	CcSEcCtD
Benzphetamine—Diarrhoea—Prednisone—multiple sclerosis	0.000376	0.00436	CcSEcCtD
Benzphetamine—Nausea—Betamethasone—multiple sclerosis	0.000375	0.00434	CcSEcCtD
Benzphetamine—Nausea—Dexamethasone—multiple sclerosis	0.000375	0.00434	CcSEcCtD
Benzphetamine—Urticaria—Methotrexate—multiple sclerosis	0.000365	0.00423	CcSEcCtD
Benzphetamine—Dizziness—Prednisone—multiple sclerosis	0.000363	0.00421	CcSEcCtD
Benzphetamine—Headache—Prednisone—multiple sclerosis	0.000344	0.00399	CcSEcCtD
Benzphetamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000338	0.00392	CcSEcCtD
Benzphetamine—Nausea—Prednisone—multiple sclerosis	0.000326	0.00378	CcSEcCtD
Benzphetamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000314	0.00364	CcSEcCtD
Benzphetamine—Dizziness—Methotrexate—multiple sclerosis	0.000303	0.00352	CcSEcCtD
Benzphetamine—Headache—Methotrexate—multiple sclerosis	0.000287	0.00333	CcSEcCtD
Benzphetamine—Phenytoin—ALB—multiple sclerosis	0.000281	0.0835	CrCbGaD
Benzphetamine—Nausea—Methotrexate—multiple sclerosis	0.000273	0.00316	CcSEcCtD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000238	0.00194	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000236	0.00192	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000234	0.00191	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCR1—multiple sclerosis	0.000234	0.00191	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCL13—multiple sclerosis	0.000234	0.00191	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000234	0.00191	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000231	0.00189	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00023	0.00188	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00023	0.00187	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000227	0.00185	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000219	0.00179	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000219	0.00179	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000213	0.00174	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000213	0.00174	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000211	0.00172	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000207	0.00169	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000207	0.00169	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000204	0.00166	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000198	0.00162	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000197	0.00161	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000193	0.00158	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000188	0.00154	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000183	0.00149	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CCL3—multiple sclerosis	0.000179	0.00146	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000179	0.00146	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000178	0.00145	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000177	0.00145	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000175	0.00143	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SRM—multiple sclerosis	0.000174	0.00142	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SELE—multiple sclerosis	0.000173	0.00141	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000173	0.00141	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000167	0.00136	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCL3—multiple sclerosis	0.000167	0.00136	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	0.000166	0.00136	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000166	0.00136	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000166	0.00135	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000165	0.00134	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000164	0.00134	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000163	0.00133	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SRM—multiple sclerosis	0.000163	0.00133	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000162	0.00132	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—PTGER4—multiple sclerosis	0.00016	0.00131	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00016	0.00131	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00016	0.00131	CbGpPWpGaD
Benzphetamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000159	0.0013	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000156	0.00127	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000155	0.00126	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000153	0.00124	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000152	0.00124	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	0.000151	0.00123	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCR2—multiple sclerosis	0.000151	0.00123	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	0.00015	0.00122	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000149	0.00122	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000149	0.00122	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	0.000147	0.0012	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000147	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000145	0.00118	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—MAPK1—multiple sclerosis	0.000144	0.00118	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000142	0.00116	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000142	0.00116	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000142	0.00116	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000141	0.00115	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CNR1—multiple sclerosis	0.000139	0.00114	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—RGS1—multiple sclerosis	0.000139	0.00113	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000137	0.00112	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	0.000137	0.00112	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000135	0.0011	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000132	0.00108	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000132	0.00108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GPR65—multiple sclerosis	0.000131	0.00107	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000129	0.00105	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000129	0.00105	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000129	0.00105	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000129	0.00105	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000128	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LINGO1—multiple sclerosis	0.000127	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—POMC—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ITGA4—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IFNB1—multiple sclerosis	0.000124	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP24A1—multiple sclerosis	0.000122	0.000999	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP27B1—multiple sclerosis	0.000122	0.000999	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00012	0.00098	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL13—multiple sclerosis	0.00012	0.00098	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCR1—multiple sclerosis	0.00012	0.00098	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000118	0.000967	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000116	0.000947	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	0.000115	0.000936	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	0.000115	0.000936	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000112	0.000916	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPC5—multiple sclerosis	0.000112	0.000914	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TAGAP—multiple sclerosis	0.00011	0.000898	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCL5—multiple sclerosis	0.000108	0.00088	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000107	0.000876	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000105	0.000857	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPC5—multiple sclerosis	0.000105	0.000856	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000105	0.000853	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000104	0.000845	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000101	0.000822	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	9.97e-05	0.000814	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	9.76e-05	0.000797	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	9.76e-05	0.000796	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	9.74e-05	0.000795	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCR5—multiple sclerosis	9.72e-05	0.000793	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—S1PR1—multiple sclerosis	9.62e-05	0.000785	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	9.43e-05	0.000769	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	9.36e-05	0.000764	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—RRM1—multiple sclerosis	9.28e-05	0.000757	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	9.21e-05	0.000752	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	9.17e-05	0.000748	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	9.07e-05	0.00074	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	8.86e-05	0.000723	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	8.81e-05	0.000719	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	8.76e-05	0.000715	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—RRM1—multiple sclerosis	8.7e-05	0.00071	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	8.6e-05	0.000702	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	8.56e-05	0.000699	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	8.56e-05	0.000699	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	8.56e-05	0.000698	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	8.52e-05	0.000695	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	8.46e-05	0.000691	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.42e-05	0.000687	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	8.35e-05	0.000681	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	8.33e-05	0.00068	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	8.24e-05	0.000672	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8.2e-05	0.000669	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	8.18e-05	0.000668	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	8.17e-05	0.000667	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	8e-05	0.000653	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	7.95e-05	0.000649	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	7.86e-05	0.000642	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	7.76e-05	0.000633	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	7.74e-05	0.000632	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	7.69e-05	0.000627	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	7.63e-05	0.000623	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	7.63e-05	0.000623	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	7.62e-05	0.000622	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	7.6e-05	0.00062	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	7.59e-05	0.00062	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.46e-05	0.000608	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	7.45e-05	0.000608	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	7.43e-05	0.000606	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SRM—multiple sclerosis	7.4e-05	0.000604	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	7.14e-05	0.000583	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	7.09e-05	0.000579	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	7.09e-05	0.000579	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	7.08e-05	0.000578	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	6.92e-05	0.000565	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.86e-05	0.00056	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	6.56e-05	0.000535	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	6.43e-05	0.000525	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.3e-05	0.000514	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ALB—multiple sclerosis	6.19e-05	0.000505	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	6.1e-05	0.000497	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	5.96e-05	0.000486	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	5.91e-05	0.000482	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.82e-05	0.000475	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	5.53e-05	0.000452	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	5.49e-05	0.000448	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	5.44e-05	0.000444	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.41e-05	0.000442	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	5.37e-05	0.000438	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—BCHE—multiple sclerosis	5.33e-05	0.000435	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	5.29e-05	0.000432	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	5.24e-05	0.000427	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.21e-05	0.000426	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.21e-05	0.000426	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	5.16e-05	0.000421	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	5.06e-05	0.000413	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	5.05e-05	0.000413	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IL2—multiple sclerosis	5.02e-05	0.00041	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	5.01e-05	0.000409	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—BCHE—multiple sclerosis	4.99e-05	0.000408	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	4.99e-05	0.000407	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	4.92e-05	0.000402	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	4.91e-05	0.000401	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	4.87e-05	0.000397	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	4.79e-05	0.000391	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.77e-05	0.000389	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	4.7e-05	0.000383	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	4.66e-05	0.00038	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	4.62e-05	0.000377	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	4.57e-05	0.000373	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	4.54e-05	0.000371	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	4.29e-05	0.00035	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	4.22e-05	0.000344	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	4.19e-05	0.000342	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	4.1e-05	0.000335	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	4.09e-05	0.000334	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.95e-05	0.000322	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	3.92e-05	0.00032	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	3.9e-05	0.000318	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	3.84e-05	0.000313	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	3.81e-05	0.000311	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	3.8e-05	0.00031	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	3.73e-05	0.000304	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	3.57e-05	0.000292	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	3.52e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	3.46e-05	0.000283	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	3.41e-05	0.000279	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	3.32e-05	0.000271	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	3.27e-05	0.000267	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	3.26e-05	0.000266	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—multiple sclerosis	3.21e-05	0.000262	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	3.17e-05	0.000259	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	3.17e-05	0.000259	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	3.12e-05	0.000255	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	3.1e-05	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	3.03e-05	0.000247	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—multiple sclerosis	3e-05	0.000245	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	2.95e-05	0.00024	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	2.9e-05	0.000237	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	2.88e-05	0.000235	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	2.88e-05	0.000235	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—POMC—multiple sclerosis	2.75e-05	0.000225	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	2.68e-05	0.000219	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	2.61e-05	0.000213	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—POMC—multiple sclerosis	2.58e-05	0.000211	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—multiple sclerosis	2.51e-05	0.000205	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	2.48e-05	0.000202	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	2.42e-05	0.000198	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	2.42e-05	0.000198	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.37e-05	0.000194	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—multiple sclerosis	2.35e-05	0.000192	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	2.3e-05	0.000188	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.27e-05	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	2.25e-05	0.000184	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	2.2e-05	0.00018	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	2.2e-05	0.00018	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	2.05e-05	0.000167	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.83e-05	0.000149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.82e-05	0.000149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.73e-05	0.000141	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.7e-05	0.000139	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.69e-05	0.000138	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.61e-05	0.000131	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.54e-05	0.000126	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.43e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.43e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.43e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.4e-05	0.000114	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000111	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.33e-05	0.000109	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.33e-05	0.000108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1.3e-05	0.000106	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.17e-05	9.57e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.08e-05	8.79e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—multiple sclerosis	1.07e-05	8.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1e-05	8.16e-05	CbGpPWpGaD
